What is the use of Cognex? The Discontinued Drug for Alzheimer's
•
4 min read
Cognex (tacrine) was the first drug approved by the FDA for the treatment of mild-to-moderate dementia of the Alzheimer's type. This milestone drug, introduced in 1993, served as a foundational but flawed treatment, eventually withdrawn from the market due to significant safety concerns, primarily liver toxicity.
